Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Larry Buie
Phase I Trial of Vinflunine and Pemetrexed in Refractory Solid Tumors
Investigational New Drugs
Oncology
Pharmacology
Related publications
A Phase I Trial of UCN-01 and Prednisone in Patients With Refractory Solid Tumors and Lymphomas
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
Phase I Trial of 90y-Dotatoc Therapy in Children and Young Adults With Refractory Solid Tumors That Express Somatostatin Receptors
Journal of Nuclear Medicine
Medicine
Nuclear Medicine
Radiology
Imaging
A Phase I Trial of Vorinostat and Bortezomib in Children With Refractory or Recurrent Solid Tumors: A Children's Oncology Group Phase I Consortium Study (ADVL0916)
Pediatric Blood and Cancer
Oncology
Child Health
Hematology
Perinatology
Medicine
Pediatrics
Phase I Trial of Weekly Topotecan and Gemcitabine in Patients With Solid Tumors
American Journal of Clinical Oncology: Cancer Clinical Trials
Cancer Research
Oncology
Phase I Trial and Pharmacokinetic Study of Ixabepilone Administered Daily for 5 Days in Children and Adolescents With Refractory Solid Tumors
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Phase I Trial of Hedgehog Pathway Inhibitor Vismodegib (GDC-0449) in Patients With Refractory, Locally Advanced or Metastatic Solid Tumors
Clinical Cancer Research
Cancer Research
Oncology
A Phase I Trial of SJG-136 (NSC#694501) in Advanced Solid Tumors
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
Phase I Study of 17-Allylamino-17 Demethoxygeldanamycin, Gemcitabine and/or Cisplatin in Patients With Refractory Solid Tumors
Investigational New Drugs
Oncology
Pharmacology
Phase I and Pharmacokinetic Study of the Vascular‐disrupting Agent CKD‐516 (NOV120401) in Patients With Refractory Solid Tumors
Pharmacology Research and Perspectives
Toxicology
Neurology
Pharmaceutics
Pharmacology
